Gene · 10481
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hereditary cancer syndromes. | World J Clin Oncol | 2023 | 36908677 | PubTator, text mining | PubMed |
| RNA N6-methyladenosine modification in female reproductive biology and pathophysiology. | Cell Commun Signal | 2023 | 36894952 | PubTator, text mining | PubMed |
| Prognostic values of long noncoding RNA in bone metastasis of prostate cancer: A systematic review and meta-analysis. | Front Oncol | 2023 | 36890836 | PubTator, text mining | PubMed |
| Are population level familial risks and germline genetics meeting each other? | Hered Cancer Clin Pract | 2023 | 36882784 | PubTator, text mining | PubMed |
| LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer. | Cancer Res | 2023 | 36877164 | PubTator, text mining | PubMed |
| mRNA-Based Therapeutics in Cancer Treatment. | Pharmaceutics | 2023 | 36839944 | PubTator, text mining | PubMed |
| A Systematic Pan-Cancer Analysis of MEIS1 in Human Tumors as Prognostic Biomarker and Immunotherapy Target. | J Clin Med | 2023 | 36836180 | PubTator, text mining | PubMed |
| Pharmacological Efficacy of Repurposing Drugs in the Treatment of Prostate Cancer. | Int J Mol Sci | 2023 | 36835564 | PubTator, text mining | PubMed |
| Blood-Based mRNA Tests as Emerging Diagnostic Tools for Personalised Medicine in Breast Cancer. | Cancers (Basel) | 2023 | 36831426 | PubTator, text mining | PubMed |
| mRNA-From COVID-19 Treatment to Cancer Immunotherapy. | Biomedicines | 2023 | 36830845 | PubTator, text mining | PubMed |
| Underlying Features of Prostate Cancer-Statistics, Risk Factors, and Emerging Methods for Its Diagnosis. | Curr Oncol | 2023 | 36826139 | PubTator, text mining | PubMed |
| Cooperation between NSPc1 and DNA methylation represses HOXA11 expression and promotes apoptosis of trophoblast cells during preeclampsia. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 36815373 | PubTator, text mining | PubMed |
| DNA repair deficiency as circulating biomarker in prostate cancer. | Front Oncol | 2023 | 36793600 | PubTator, text mining | PubMed |
| CHD1, a multifaceted epigenetic remodeler in prostate cancer. | Front Oncol | 2023 | 36776288 | PubTator, text mining | PubMed |
| Potential prognostic role of somatic mutations in a set of cancer susceptibility genes in ovarian carcinoma: A follow-up multicentric study from Pakistan. | Cancer Biomark | 2023 | 36776043 | PubTator, text mining | PubMed |
| Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting. | Int J Mol Sci | 2023 | 36769263 | PubTator, text mining | PubMed |
| Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment. | Int J Mol Sci | 2023 | 36768610 | PubTator, text mining | PubMed |
| The prostate in women: an updated histological and immunohistochemical profile of the female periurethral glands and their relationship to an implanted midurethral sling. | J Sex Med | 2023 | 36763941 | PubTator, text mining | PubMed |
| Whole-body adipose tissue multi-omic analyses in sheep reveal molecular mechanisms underlying local adaptation to extreme environments. | Commun Biol | 2023 | 36755107 | PubTator, text mining | PubMed |
| Genetic and phenotypic continuum of HOXA genes: A case with double HOXA9/HOXA13 mutations. | Mol Med Rep | 2023 | 36734258 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10481/papers?page=17